FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice

Y. Paalvast; E. Zhou; N. L. Mulder; M. Koehorst; R. Boverhof; K. Willems van Dijk; P. C. N. Rensen; J. A. Kuivenhoven; C. Kremoser; Y. Wang; F. Kuipers; A. K. Groen; J. F. de Boer

doi:10.1016/j.atherosclerosis.2018.06.914

FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice

Y. Paalvast, E. Zhou, N. L. Mulder, M. Koehorst, R. Boverhof, K. Willems van Dijk, P. C. N. Rensen, J. A. Kuivenhoven, C. Kremoser, Y. Wang, F. Kuipers, A. K. Groen, J. F. de Boer

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	E10
Aantal pagina's	1
Tijdschrift	Atherosclerosis
Volume	275
DOI's	https://doi.org/10.1016/j.atherosclerosis.2018.06.914
Status	Published - aug.-2018
Evenement	86th Congress of the European-Atherosclerosis-Society (EAS) - Lisbon, Portugal Duur: 5-mei-2018 → 8-mei-2018

Toegang tot document

10.1016/j.atherosclerosis.2018.06.914

Handle.net

Permanente koppeling

Citeer dit

Paalvast, Y., Zhou, E., Mulder, N. L., Koehorst, M., Boverhof, R., van Dijk, K. W., Rensen, P. C. N., Kuivenhoven, J. A., Kremoser, C., Wang, Y., Kuipers, F., Groen, A. K., & de Boer, J. F. (2018). FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice. Atherosclerosis, 275, E10. https://doi.org/10.1016/j.atherosclerosis.2018.06.914

@article{9c1a2935f2b8405e82a7fb9057a1f0b8,

title = "FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice",

author = "Y. Paalvast and E. Zhou and Mulder, {N. L.} and M. Koehorst and R. Boverhof and {van Dijk}, {K. Willems} and Rensen, {P. C. N.} and Kuivenhoven, {J. A.} and C. Kremoser and Y. Wang and F. Kuipers and Groen, {A. K.} and {de Boer}, {J. F.}",

year = "2018",

month = aug,

doi = "10.1016/j.atherosclerosis.2018.06.914",

language = "English",

volume = "275",

pages = "E10",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "ELSEVIER IRELAND LTD",

note = "86th Congress of the European-Atherosclerosis-Society (EAS) ; Conference date: 05-05-2018 Through 08-05-2018",

}

Paalvast, Y, Zhou, E, Mulder, NL, Koehorst, M, Boverhof, R, van Dijk, KW, Rensen, PCN, Kuivenhoven, JA, Kremoser, C, Wang, Y, Kuipers, F, Groen, AK & de Boer, JF 2018, 'FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice', Atherosclerosis, vol. 275, blz. E10. https://doi.org/10.1016/j.atherosclerosis.2018.06.914

TY - JOUR

T1 - FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice

AU - Paalvast, Y.

AU - Zhou, E.

AU - Mulder, N. L.

AU - Koehorst, M.

AU - Boverhof, R.

AU - van Dijk, K. Willems

AU - Rensen, P. C. N.

AU - Kuivenhoven, J. A.

AU - Kremoser, C.

AU - Wang, Y.

AU - Kuipers, F.

AU - Groen, A. K.

AU - de Boer, J. F.

PY - 2018/8

Y1 - 2018/8

U2 - 10.1016/j.atherosclerosis.2018.06.914

DO - 10.1016/j.atherosclerosis.2018.06.914

M3 - Meeting Abstract

SN - 0021-9150

VL - 275

SP - E10

JO - Atherosclerosis

JF - Atherosclerosis

T2 - 86th Congress of the European-Atherosclerosis-Society (EAS)

Y2 - 5 May 2018 through 8 May 2018

ER -